Skip to main content
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1998;6(4):182–185. doi: 10.1002/(SICI)1098-0997(1998)6:4<182::AID-IDOG8>3.0.CO;2-T

Clinical utility of CA125 levels in predicting laparoscopically confirmed salpingitis in patients with clinically diagnosed pelvic inflammatory disease.

E Moore 1, D E Soper 1
PMCID: PMC1784794  PMID: 9812251

Abstract

OBJECTIVE: The purpose of this study was to determine the utility of serum CA125 determinations in diagnosing acute salpingitis. METHODS: CA125 levels were determined for 34 women with the clinical diagnosis of pelvic inflammatory disease (PID). Acute salpingitis was confirmed laparoscopically in 28 women (82.3%). RESULTS: Twenty patients (71.4%) with laparoscopically confirmed acute salpingitis had CA125 levels greater than 7.5 units, compared with no patients (0/6) with laparoscopically normal tubes (P = 0.002). The degree of elevation of CA125 levels correlated with the severity of tubal inflammation noted at laparoscopy. All patients with levels above 16 units had laparoscopically severe salpingitis. CONCLUSIONS: We conclude that while CA125 levels above 7.5 units may modestly improve the ability of the clinical diagnosis of PID to accurately reflect visually confirmed acute salpingitis, limitations of the test make its clinical utility questionable.

Full Text

The Full Text of this article is available as a PDF (347.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bast R. C., Jr, Klug T. L., St John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13;309(15):883–887. doi: 10.1056/NEJM198310133091503. [DOI] [PubMed] [Google Scholar]
  2. Brumsted J. R., Mead P. B., Gibson M. Serum concentration of protein CA-125 in women with pelvic inflammatory disease. Sex Transm Dis. 1988 Jul-Sep;15(3):144–147. doi: 10.1097/00007435-198807000-00005. [DOI] [PubMed] [Google Scholar]
  3. Duk J. M., Kauer F. M., Fleuren G. J., de Bruijn H. W. Serum CA 125 levels in patients with a provisional diagnosis of pelvic inflammatory disease. Clinical and theoretical implications. Acta Obstet Gynecol Scand. 1989;68(7):637–641. doi: 10.3109/00016348909013284. [DOI] [PubMed] [Google Scholar]
  4. Jacobs I., Bast R. C., Jr The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod. 1989 Jan;4(1):1–12. doi: 10.1093/oxfordjournals.humrep.a136832. [DOI] [PubMed] [Google Scholar]
  5. Jaeschke R., Guyatt G. H., Sackett D. L. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994 Mar 2;271(9):703–707. doi: 10.1001/jama.271.9.703. [DOI] [PubMed] [Google Scholar]
  6. Paavonen J., Miettinen A., Heinonen P. K., Aaran R. K., Teisala K., Aine R., Punnonen R., Laine S., Kallioniemi O. P., Lehtinen M. Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol. 1989 May;96(5):574–579. doi: 10.1111/j.1471-0528.1989.tb03259.x. [DOI] [PubMed] [Google Scholar]
  7. Soper D. E., Brockwell N. J., Dalton H. P. Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. Am J Obstet Gynecol. 1992 Sep;167(3):653–660. doi: 10.1016/s0002-9378(11)91566-x. [DOI] [PubMed] [Google Scholar]
  8. Svensson L., Weström L., Ripa K. T., Mårdh P. A. Differences in some clinical and laboratory parameters in acute salpingitis related to culture and serologic findings. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):1017–1021. doi: 10.1016/0002-9378(80)91099-6. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES